Therefore we aimed to confirm whether IDH1/2 mutation induced hyper- and hypomethylation showed similar effect on promoters, enhancers and gene bodies across all six IDH1/2 mutated cancer types including tumors in which we did not have the wild-type tumor or normal tissue for comparison. Here, IDH1 is linked to cancer.